Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 4/20 | 0.59 |
| ▸ | CNR1 | P21554 | 2/20 | 0.59 |
| ▸ | CNR2 | P34972 | 2/20 | 0.59 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.59 |
| ▸ | PPARG | P37231 | 6/20 | 0.59 |
| ▸ | PPARD | Q03181 | 6/20 | 0.59 |
| ▸ | PPARA | Q07869 | 6/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FABP4 | P15090 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Palmitic Acid SCHEMBL29013359 | 1.00 | EPHX2 (0.65) | EPHX2KDM4EFAAHCNR1CNR2 | |
| Stearic Acid SCHEMBL28850717 | 1.00 | EPHX2 (0.65) | EPHX2KDM4EFAAHCNR1CNR2 | |
| Stearic Acid SCHEMBL29013367 | 1.00 | EPHX2 (0.65) | EPHX2KDM4EFAAHCNR1CNR2 | |
| Propionic Acid SCHEMBL28385729 | 0.93 | SLC6A5 (0.59) | EPHX2KDM4EFAAHCNR1CNR2 | |
| SCHEMBL23673836 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 | |
| SCHEMBL7777076 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 | |
| SCHEMBL6894367 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 | |
| SCHEMBL3910766 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 | |
| SCHEMBL10031646 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 | |
| SCHEMBL1813350 | 0.93 | FAAH (0.67) | EPHX2FAAHCNR1SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | EPHX2 580/4885KDM4E 3681/4885FAAH 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.